Modern LC-MS bioanalysis across therapeutic modalities

Modern LC-MS strategies to generate confident results across molecule types and workflows

#000
Overview
sciextext
Speakers
speakers
sciextext
text-left

Bioanalysis is evolving as therapeutic drug candidates diversify and analytical demands increase. From small molecules to complex biomolecules, scientists rely on advanced LC‑MS to deliver confident, timely results across research and development.

Modern LC‑MS technologies combine robust separation, sensitive detection, and identification to address bioanalytical challenges across analytes of all sizes.

Explore curated expert insights, real‑world examples, and proven strategies advancing bioanalysis for peptides, proteins, oligonucleotides, and targeted protein degraders.

What You’ll Learn:

  • Understand key assays shaping bioanalysis across therapeutic modalities
  • Apply effective LC‑MS‑based strategies to accelerate bioanalytical decisions
  • Select the right bioanalytical approach for your application, informed by real‑world laboratory success stories
registerform
Learn more
https://info.sciex.com/LP=5763
one-column
900px
speakers

Speakers

speakers
Dawn Dufield, Scientific Officer - Mass Spectrometry, KCAS Bio
speakers
Shane Karnik, Senior Laboratory Director, Aliri Bioanalysis
speakers
Shane Needham, Co-Founder, President and CEO, Veloxity Labs
speakers
Rathna Veeramachaneni, Director - Pharma Development, KCAS Bio